ES2081463T3 - 1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen. - Google Patents

1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen.

Info

Publication number
ES2081463T3
ES2081463T3 ES91830276T ES91830276T ES2081463T3 ES 2081463 T3 ES2081463 T3 ES 2081463T3 ES 91830276 T ES91830276 T ES 91830276T ES 91830276 T ES91830276 T ES 91830276T ES 2081463 T3 ES2081463 T3 ES 2081463T3
Authority
ES
Spain
Prior art keywords
learning
caprolactamas
acilamino
pharmaceutical compositions
alquil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91830276T
Other languages
English (en)
Inventor
Fabio Giannessi
Orlando Ghirardi
Domenico Misiti
Maria Ornella Tinti
Roberto Cozzolino
Carlo Scolastico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2081463T3 publication Critical patent/ES2081463T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1-ALQUIL-3-(ACILAMINO)-CAPROLACTAMAS DE FORMULA (1). EN LA QUE R ES ELEGIDO ENTRE EL GRUPO QUE CONSISTE DE PIROLIDIN-2-ONA-1 -ACETILO, P-METOXIBENZOILO. N-BENZILOXICARBONIL-(S)-PROLILO, FENILBUTANOILO, 3-TRIFLUOROMETILBENZOILO, 3, 4, 5-TRIMETOXIBENZOILO, NICOTINOILO, Y ACILO QUE TIENE ENTRE 1 Y 5 ATOMOS DE CARBONO, Y R SUB 1 ES ELEGIDO ENTRE EL GRUPO QUE CONSISTE EN: HIDROGENO, METOXICARBONILMETILO, AMINOCARBONILMETILO, 2-HIDROXIETILO, Y FORMILMETILO, (SIEMPRE Y CUANDO QUE, SI R SUB 1 ES HIDROGENO, R NO ES FORMILO O ACETILO) SON POTENTES MEJORADORES DEL APRENDIZAJE Y DE LA MEMORIA. LAS COMPOSICIONES FARMACEUTICAS ADMINISTRABLES POR VIA ORAL O PARENTERAL EN FORMA DE DOSIS UNITARIA COMPRENDEN APROXIMADAMENTE ENTRE 100 Y 500 MG DE UNO DE LOS COMPUESTOS DE FORMULA (1).
ES91830276T 1990-06-21 1991-06-20 1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen. Expired - Lifetime ES2081463T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04808790A IT1247698B (it) 1990-06-21 1990-06-21 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Publications (1)

Publication Number Publication Date
ES2081463T3 true ES2081463T3 (es) 1996-03-16

Family

ID=11264450

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91830276T Expired - Lifetime ES2081463T3 (es) 1990-06-21 1991-06-20 1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen.

Country Status (9)

Country Link
US (1) US5155102A (es)
EP (1) EP0462949B1 (es)
JP (1) JPH04230266A (es)
AT (1) ATE131159T1 (es)
DE (1) DE69115135T2 (es)
DK (1) DK0462949T3 (es)
ES (1) ES2081463T3 (es)
GR (1) GR3019076T3 (es)
IT (1) IT1247698B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344450B1 (en) 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
AU756174B2 (en) * 1999-02-09 2003-01-09 Bristol-Myers Squibb Company Lactam inhibitors of FXa and method
AU760174B2 (en) 1999-02-09 2003-05-08 Bristol-Myers Squibb Company Lactam inhibitors of FXa and method
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
TWI356821B (en) * 2003-12-01 2012-01-21 Cambridge Entpr Ltd Anti-inflammatory agents
BRPI0507971A (pt) * 2004-02-23 2007-07-24 Tufts College composto, composição farmacêutica, uso de um composto,método para inibir a atividade proteolìtica de uma enzima de clivagem pós-prolina e remédio empacotado
GB2418425B (en) * 2004-08-11 2008-09-03 Univ Cambridge Tech Anti-inflammatory agents
GB201009603D0 (en) 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
IT1231477B (it) * 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Also Published As

Publication number Publication date
IT1247698B (it) 1994-12-30
EP0462949A1 (en) 1991-12-27
DE69115135T2 (de) 1996-05-09
JPH04230266A (ja) 1992-08-19
EP0462949B1 (en) 1995-12-06
GR3019076T3 (en) 1996-05-31
ATE131159T1 (de) 1995-12-15
DK0462949T3 (da) 1996-02-05
IT9048087A0 (it) 1990-06-21
US5155102A (en) 1992-10-13
DE69115135D1 (de) 1996-01-18
IT9048087A1 (it) 1991-12-21

Similar Documents

Publication Publication Date Title
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
ES2144403T3 (es) Derivados de tiazol como inhibidores de oxigeno activo.
ES2176252T3 (es) Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos.
LU90856I2 (fr) Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
ES2058630T3 (es) Derivados de 2-(1-piperazinil)-4-fenilcicloalcanopiridinas, procedimientos de preparacion y composiciones farmaceuticas que los contienen.
ES2191412T3 (es) Derivados de aminoacidos que contienen fluor.
ES2104015T3 (es) Derivado del acido metoxiiminoacetico y fungicida agricola/horticola que lo contiene como ingrediente activo.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
IL47529A (en) Substituted (1-(-4,4-bisphenylbutyl)-4-piperidyl-)1,3-dihydro-2h-benzimidazol-2-one derivatives and certain intermediates for obtaining such compounds,their preparation and pharmaceutical compositions containing them
ES2081463T3 (es) 1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen.
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
ES452200A1 (es) Un procedimiento para la preparacion de nuevos derivados de pipendina.
ES2145064T3 (es) Compuestos de penem sustituidos con metileno en posicion 6 y productos intermedios.
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
AR027578A1 (es) Derivados de indano
ES2067206T3 (es) Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria.
DE69423402D1 (de) Stabile, pharmazeutische Zusammensetzungen die hybrid alpha-Interferon enthalten
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
GT199500039AA (es) Compuestos ariltios
NO941084L (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
TW344743B (en) Therapeutic nucleosides
ATE40988T1 (de) Acylierte enamidverbindungen, diese enthaltende pharmazeutische zusammensetzungen und verwendung dieser verbindungen.
ES2078723T3 (es) 3-acilamino-2-pirrolidinonas como potenciadores de los procesos de aprendizaje y de la memoria y composiciones farmaceuticas que las contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 462949

Country of ref document: ES